Total Payments
$6,544
2024 Payments
$747.94
Companies
46
Transactions
246
Medicare Patients
3,019
Medicare Billing
$713,355
Payment Breakdown by Category
Food & Beverage$4,140 (63.3%)
Consulting$1,575 (24.1%)
Travel$817.78 (12.5%)
Education$10.65 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,140 | 239 | 63.3% |
| Consulting Fee | $1,575 | 1 | 24.1% |
| Travel and Lodging | $817.78 | 5 | 12.5% |
| Education | $10.65 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,617 | 15 | $0 (2024) |
| Amgen Inc. | $613.79 | 38 | $0 (2024) |
| Novo Nordisk Inc | $495.67 | 26 | $0 (2024) |
| Lilly USA, LLC | $448.90 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $206.07 | 13 | $0 (2023) |
| Exact Sciences Corporation | $185.67 | 10 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $183.35 | 11 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $162.97 | 7 | $0 (2024) |
| Antares Pharma, Inc. | $141.88 | 9 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $133.30 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $747.94 | 40 | Amgen Inc. ($134.18) |
| 2023 | $868.98 | 44 | Lilly USA, LLC ($163.87) |
| 2022 | $510.42 | 31 | Amgen Inc. ($138.43) |
| 2021 | $626.65 | 36 | Amarin Pharma Inc. ($91.46) |
| 2020 | $259.80 | 17 | Amgen Inc. ($66.71) |
| 2019 | $238.12 | 15 | Novo Nordisk Inc ($59.94) |
| 2018 | $373.92 | 25 | Amgen Inc. ($67.15) |
| 2017 | $2,918 | 38 | AbbVie, Inc. ($2,538) |
All Payment Transactions
246 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Cardio-renal | ||||||
| 12/05/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/03/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Bone Health | ||||||
| 12/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.15 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Endocrinology | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Cardio-renal | ||||||
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Cardio-renal | ||||||
| 09/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Diabetes | ||||||
| 09/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Oncology | ||||||
| 09/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: UROLOGY | ||||||
| 09/05/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Cardio-renal | ||||||
| 08/26/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Inflammation | ||||||
| 08/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Bone Health | ||||||
| 07/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Cardio-renal | ||||||
| 07/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 805 | 2,492 | $479,075 | $202,839 |
| 2022 | 9 | 759 | 2,307 | $426,443 | $169,871 |
| 2021 | 8 | 717 | 2,215 | $415,254 | $169,458 |
| 2020 | 9 | 738 | 2,292 | $421,261 | $171,186 |
Total Patients
3,019
Total Services
9,306
Medicare Billing
$713,355
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 272 | 1,143 | $228,600 | $106,839 | 46.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 193 | 778 | $115,046 | $48,336 | 42.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 183 | 194 | $79,152 | $26,410 | 33.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 186 | $39,618 | $15,864 | 40.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $6,346 | $2,021 | 31.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 31 | 37 | $4,033 | $1,452 | 36.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 32 | $4,672 | $1,303 | 27.9% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 27 | 46 | $1,380 | $568.10 | 41.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 57 | $228.00 | $47.24 | 20.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 251 | 998 | $199,600 | $80,900 | 40.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 160 | 603 | $88,038 | $33,993 | 38.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 158 | 170 | $69,360 | $26,395 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 237 | $50,481 | $21,706 | 43.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $5,678 | $2,263 | 39.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 16 | 41 | $5,986 | $1,854 | 31.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 35 | 44 | $4,796 | $1,832 | 38.2% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 37 | 66 | $1,980 | $822.01 | 41.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 19 | 131 | $524.00 | $106.68 | 20.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 233 | 957 | $191,400 | $78,675 | 41.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 157 | 609 | $88,914 | $35,063 | 39.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 162 | 184 | $75,072 | $29,331 | 39.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 56 | 200 | $42,600 | $19,615 | 46.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 32 | 76 | $11,096 | $4,367 | 39.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 31 | 34 | $3,706 | $1,426 | 38.5% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 35 | 71 | $2,130 | $894.60 | 42.0% |
About Dr. Michael Yu, MD
Dr. Michael Yu, MD is a Physical Medicine & Rehabilitation healthcare provider based in Clearwater, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1891782835.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Yu, MD has received a total of $6,544 in payments from pharmaceutical and medical device companies, with $747.94 received in 2024. These payments were reported across 246 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($4,140).
As a Medicare-enrolled provider, Yu has provided services to 3,019 Medicare beneficiaries, totaling 9,306 services with total Medicare billing of $713,355. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Clearwater, FL
- Active Since 10/04/2005
- Last Updated 06/17/2008
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1891782835
Products in Payments
- EVENITY (Biological) $300.29
- JARDIANCE (Drug) $207.58
- MOUNJARO (Drug) $203.23
- Cologuard Collection Kit (Device) $185.67
- Otezla (Drug) $184.72
- Kerendia (Drug) $183.35
- Ozempic (Drug) $148.40
- Rybelsus (Drug) $145.23
- ENTRESTO (Drug) $129.23
- Vascepa (Drug) $124.43
- NURTEC ODT (Drug) $103.71
- EMGALITY (Drug) $102.09
- Aimovig (Biological) $99.90
- XARELTO (Drug) $88.52
- FARXIGA (Drug) $84.08
- XYOSTED (Drug) $82.52
- MYRISK (Device) $82.34
- LEQVIO (Drug) $76.84
- Tresiba (Drug) $76.18
- SOLIQUA (Drug) $71.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Clearwater
Dr. Francisco Torres, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $2,978
Physical Medicine & Rehabilitation $2,978
Craig Schwartz, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $1,199
Physical Medicine & Rehabilitation $1,199
Dr. Constantine Bouchlas, Md, MD
Physical Medicine & Rehabilitation — Payments: $1,034
Physical Medicine & Rehabilitation $1,034
Dr. Kenneth Botwin, Md, MD
Physical Medicine & Rehabilitation — Payments: $681.41
Physical Medicine & Rehabilitation $681.41
Marc Reiskind, Md, MD
Physical Medicine & Rehabilitation — Payments: $670.58
Physical Medicine & Rehabilitation $670.58
Dr. Kevin Creed, Md, MD
Physical Medicine & Rehabilitation — Payments: $667.13
Physical Medicine & Rehabilitation $667.13